.svg){kind=icon}
Featured Abstracts
What are the challenges for building real world comparative cohorts in oncology?
Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement
IQVIA Authors
Nikita Jeswani, Amanda McDonell, Finlay MacDougall, Jeff Paul Hodge
Leveraging real world data and AIML to inform smart patient care in oncology
Abstract in ASCO20 Virtual Scientific Program: Hematologic Malignancies—Lymphoma and Chronic Lymphocytic Leukemia
IQVIA Authors
Li Zhou, Rob Steen, Lynn Lu
Patient trial matching using pseudo-siamese network
Abstract in ASCO20 Virtual Scientific Program: Care Delivery and Regulatory Policy
IQVIA Authors
Cao Xiao, Junyi Gao, Lucas Glass, Jimeng Sun
MSI/MMR test usage and checkpoint inhibitor practices in Europe.
Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement
AUTHORS
Bradley Smith, Jeffrey Hodge, Caroline Anger, Fil Manuguid, Kriti Jindal; IQVIA, Marblehead, MA; IQVIA, Durham, NC; IQVIA, London, United Kingdom
View Abstract
Real-world clinical and economic burden associated with hospitalization in metastatic triple-negative (ER-/PR-/HER2-) breast cancer.
Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement
AUTHORS
Amie Tan, Xu Han, Aimee Near, Jenny Tse, Luciana Preger; Genentech, Inc., South San Francisco, CA; IQVIA, Durham, NC
VIEW ABSTRACT
Trends in immunotherapy use in patients with advanced non-small cell lung cancer (aNSCLC) patients: Analysis of real-world data.
Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement
AUTHORS
Lawrence H. Kushi, Laura Lasiter, Andrew J. Belli, Marley Boyd, Suanna S. Bruinooge, Jennifer Christian, Elizabeth Garrett-Mayer, Eric Hansen, Rebecca Honnold, Ruth Pe Benito, Yanina Natanzon, Lori Sakoda, Donna R. R Rivera, Whitney Rhodes, Nicholas J. Robert, Elad Sharon, Connor Sweetnam, Joseph Wagner, Mark S. Walker, Jeff Allen; Kaiser Permanente, Oakland, CA; Friends of Cancer Research, Washington, DC; COTA, Inc., New York, NY; McKesson Life Sciences, The Woodlands, TX; American Society of Clinical Oncology, Alexandria, VA; IQVIA, Research Triangle Park, NC; Tempus Labs, Chicago; Tempus, Chicago, IL; Syapse, San Francisco, CA; Kaiser Permanente Northern California, Division of Research, Oakland, CA; National Cancer Institute, Rockville, MD; Concerto HealthAI, Memphis, TN; 10101 Woodloch Forest, The Woodlands, TX; National Cancer Institute, Bethesda, MD; Syapse Inc., San Francisco, CA; IQVIA, Plymouth Meeting, PA; ACORN Research LLC, Memphis, TN
VIEW ABSTRACT
Overall survival (OS) in advanced non-small cell lung cancer (aNSCLC) patients treated with frontline chemotherapy or immunotherapy by comorbidity: A real-world data (RWD) collaboration.
Abstract in ASCO20 Virtual Scientific Program: Health Services Research and Quality Improvement
AUTHOR(S)
Donna R. R Rivera, Laura Lasiter, Jennifer Christian, Lindsey Enewold, Janet L. Espirito, Eric Hansen, Henry J. Henk, Lawrence H. Kushi, Daniel Lane, Yanina Natanzon, Ruth Pe Benito, Erik Rasmussen, Nicholas J. Robert, Mark Stewart, Connor Sweetnam, Olga Tymejczyk, Emily Valice, Joseph Wagner, Alia Zander, Jeff Allen; National Cancer Institute, Rockville, MD; Friends of Cancer Research, Washington, DC; IQVIA, Research Triangle Park, NC; National Cancer Institute, Bethesda, MD; McKesson Life Sciences, The Woodlands, TX; COTA, Inc., New York, NY; OptumLabs, Shakopee, MN; Kaiser Permanente, Oakland, CA; COTA Healthcare, Boston, MA; Syapse, San Francisco, CA; Tempus, Chicago, IL; Flatiron Health, New York, NY; 10101 Woodloch Forest, The Woodlands, TX; Syapse Inc., San Francisco, CA; Kaiser Permanente Division of Research, Oakland, CA; IQVIA, Plymouth Meeting, PA
VIEW ABSTRACT
Adverse event and outcome patterns in patients with advanced multiple myeloma in the United States.
Abstract in ASCO20 Virtual Scientific Program: Hematologic Malignancies—Plasma Cell Dyscrasia
AUTHORS
Joshua Ryan Richter, Jason Yeaw, Drishti Shah, Ruthwik Anupindi, Suneel Kudaravalli, Stojan Zavisic; The Tisch Cancer Institute/Icahn School of Medicine at Mount Sinai, New York, NY; IQVIA, San Francisco; IQVIA, Falls Church, VA; Oncopeptides, Mountain View, CA; Oncopeptides AB, Stockholm, Sweden
VIEW ABSTRACT
Burden of relapsed/refractory (RR) acute myeloid leukemia.
Abstract in ASCO20 Virtual Scientific Program: Hematologic Malignancies—Leukemia, Myelodysplastic Syndromes, and Allotransplant
AUTHORS
Sumeet Panjabi, Dionne M. Hines, Catherine Balderston McGuiness, Emre Yucel, Steven Yea, Zachariah McIver, Rolin L Wade; Amgen, Inc., South San Francisco, CA; IQVIA, Plymouth Meeting, PA; Amgen, Inc, Thousand Oaks, CA
VIEW ABSTRACT
A retrospective analysis of CDK4/6 inhibitors among adult female patients with metastatic breast cancer.
Abstract in ASCO20 Virtual Scientific Program: Breast Cancer—Metastatic
AUTHORS
Silvia Comis, Thenmozhi Kandasamy, Alysa J Perrin, Kelley Kent, Mahendra Dulawat, Arun Chhikara, Nitish Ranjan; IQVIA, Milan, Italy; IQVIA, Inc., Durham, NC
VIEW ABSTRACT
Prognostic factors impacting survival in early HER2-positive breast cancer (BC): Results from a 1,142 patients database study.
Abstract in ASCO20 Virtual Scientific Program: Breast Cancer - Local/Regional/Adjuvant
AUTHORS
Roberto Hegg, Andre Mattar, Maurício Rocha, Renato Watanabe Oliveira, Guilherme Silva Julian, Luiz Henrique Gebrim; Hospital Pérola Byington, São Paulo, Brazil; Roche Brazil, São Paulo, Brazil; IQVIA, São Paulo, Brazil
VIEW ABSTRACT
Comparative effectiveness of immune-checkpoint inhibitors as first-line treatment for advanced nonsquamous non-small cell lung cancer patients: A network meta-analysis and a systematic review.
Abstract in ASCO20 Virtual Scientific Program: Lung Cancer—Non-Small Cell Metastatic
AUTHORS
Roberto Jorge Bitton, Natalia Jacob, Juan Manuel Carrera, Ezequiel Cayetano Perez; IQVIA, Buenos Aires, Argentina; Quintiles, Buenos Aires, Argentina